A Clinical Trial of Multiple Doses of GR2301 Injection in Healthy Adult Trial Participants in China.

GR2301 - Genrix Bio

A Clinical Trial of Multiple Doses of GR2301 Injection in Healthy Adult Trial Participants in China. (clinicaltrials.gov) - Jun 15, 2026 - P1 | N=36 | Not yet recruiting | Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd.
New P1 trial

http://clinicaltrials.gov/ct2/show/NCT07647224

Jun 15, 2026